Same Indication

Ipilimumab vs Levofloxacin

Ipilimumab vs Levofloxacin: Overview

This comparison examines the pharmacological differences between Ipilimumab and Levofloxacin.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Levofloxacin — 6-8 hours.

Chemical Properties

Molecular Formula: Levofloxacin — C18H20FN3O4.

Molecular Weight: Levofloxacin — 361.3680 g/mol.

Type: Ipilimumab — Antibody; Levofloxacin — Small molecule.